Aspivix

Aspivix We Develop Modern Devices for Gynecology Designed for Best Patient Experience. Results from “First in Women” Trial in Switzerland are expected in 2H2020.

ASPIVIX is a Swiss-based medical device company dedicated to R&D, Manufacturing and Sales of technologies for women’s health. Our vision is to empower women around the world by driving healthcare innovation in areas that are needed the most, thus making a positive impact in women’s everyday life. Our flagship product, is a next generation, patent protected vacuum-based cervical device that delivers the same manoeuvrability as the traumatic tenaculum - used 80 million times/year - without the reported patient trauma related to pain, bleeding, tissue tear. We believe that women deserve gentler and more modern methods for procedures in gynecology. Should you have any interest or any need for additional information, please feel free to contact us.

07/10/2025

𝗖𝗮𝗿𝗲𝘃𝗶𝘅® Across Continents – Redefining Global Gynecology
From pioneering hospitals to innovative women’s health clinics, 𝗖𝗮𝗿𝗲𝘃𝗶𝘅® is now part of daily practice across four continents.🌍

Where 𝗖𝗮𝗿𝗲𝘃𝗶𝘅® is trusted:

💜𝗦𝘄𝗶𝘁𝘇𝗲𝗿𝗹𝗮𝗻𝗱 – adopted in major hospitals like HUG Geneva and CHUV Lausanne, alongside leading private practices nationwide

💜𝗨𝗻𝗶𝘁𝗲𝗱 𝗦𝘁𝗮𝘁𝗲𝘀 – in use at Columbia University Irving Medical Center (NY), IU Health and across the fast-growing Tia Health group of clinics, amongst other

💜𝗚𝗲𝗿𝗺𝗮𝗻𝘆, 𝗨𝗞, 𝗙𝗿𝗮𝗻𝗰𝗲, 𝗦𝗽𝗮𝗶𝗻, 𝗕𝗲𝗻𝗲𝗹𝘂𝘅, 𝗦𝘄𝗲𝗱𝗲𝗻 – integrated into leading clinics and university hospitals

💜𝗕𝗿𝗮𝘇𝗶𝗹 – adopted at UNICAMP, one of Latin America’s top women’s health research centers 📈 10+ countries.

Hundreds of clinicians. Thousands of women experiencing gentler care. Every new adoption marks a shift, away from outdated instruments, toward compassionate, patient-centered gynecology.𝗖𝗮𝗿𝗲𝘃𝗶𝘅® isn’t just expanding globally, it’s setting a new standard.

🔗 Discover our global footprint: aspivix.com

Aspivix

06/10/2025

🌸 𝗠𝗲𝗲𝘁 𝗖𝗮𝗿𝗲𝘃𝗶𝘅® — 𝘁𝗵𝗲 𝗴𝗲𝗻𝘁𝗹𝗲 𝗮𝗹𝘁𝗲𝗿𝗻𝗮𝘁𝗶𝘃𝗲 𝘄𝗼𝗺𝗲𝗻 𝗱𝗲𝘀𝗲𝗿𝘃𝗲.

No more outdated, painful tools.
Just modern, safe, empowering care. 💜

💜 A gentler, safer future in women’s healthcare is here.
Available now for clinicians.
Based in the United States (LA, OC, NY), visit: www.myaspivix.us
Based in Switzerland: www.myaspivix.com

👉 Discover the story behind our mission: www.aspivix.com

🩷𝗢𝗰𝘁𝗼𝗯𝗲𝗿 𝗶𝘀 𝗕𝗿𝗲𝗮𝘀𝘁 𝗖𝗮𝗻𝗰𝗲𝗿 𝗔𝘄𝗮𝗿𝗲𝗻𝗲𝘀𝘀 𝗠𝗼𝗻𝘁𝗵🎗This month, we stand with millions of women worldwide in raising awareness, pr...
03/10/2025

🩷𝗢𝗰𝘁𝗼𝗯𝗲𝗿 𝗶𝘀 𝗕𝗿𝗲𝗮𝘀𝘁 𝗖𝗮𝗻𝗰𝗲𝗿 𝗔𝘄𝗮𝗿𝗲𝗻𝗲𝘀𝘀 𝗠𝗼𝗻𝘁𝗵🎗

This month, we stand with millions of women worldwide in raising awareness, promoting early detection, and supporting those affected by breast cancer.

At 𝗔𝘀𝗽𝗶𝘃𝗶𝘅, our mission is to redefine women’s healthcare with empathy, safety, and innovation. While our work with 𝗖𝗮𝗿𝗲𝘃𝗶𝘅® focuses on making gynecological procedures less painful, our broader vision is clear: every woman deserves care that is gentle, dignified, and proactive across all areas of health.

💡 Breast cancer remains the most common cancer among women worldwide — but early detection saves lives. Together, awareness and innovation can make a difference.

👉 𝗧𝗵𝗶𝘀 𝗢𝗰𝘁𝗼𝗯𝗲𝗿, 𝘄𝗲 𝗲𝗻𝗰𝗼𝘂𝗿𝗮𝗴𝗲 𝘆𝗼𝘂 𝘁𝗼:
✔️ Schedule your screenings
✔️ Support awareness initiatives
✔️ Share knowledge to empower others

Because women’s health deserves respect, comfort, and continuous attention — in every dimension.

02/10/2025

“𝗜𝘀 𝗖𝗮𝗿𝗲𝘃𝗶𝘅 𝗽𝗮𝗶𝗻-𝗳𝗿𝗲𝗲?”
It’s one of the most Googled questions about IUD insertion — and we get why.

Pain has long been a barrier for people seeking effective contraception. At ASPIVIX, we’re here to change that.

💜 𝗖𝗮𝗿𝗲𝘃𝗶𝘅® is designed to significantly reduce discomfort and bleeding during IUD placement.
Unlike traditional tenaculum that pierce the cervix, 𝗖𝗮𝗿𝗲𝘃𝗶𝘅® uses gentle suction — no trauma, no tissue pe*******on.

📊 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗿𝗲𝘀𝘂𝗹𝘁𝘀 𝘀𝗮𝘆 𝗶𝘁 𝗮𝗹𝗹:
➡️ 96% of gynecologists rated the device as easy to use
➡️ 94% of patients declared to be satisfied
➡️ 92% of providers said they observed reduced patient discomfort

Because when it comes to gynecological care, comfort matters.

And women deserve options that put their well-being first.

👉 Visit our website: www.aspivix.com

01/10/2025

👋 𝗪𝗲𝗹𝗰𝗼𝗺𝗲 𝘁𝗼 𝘁𝗵𝗲 𝗧𝗲𝗮𝗺!

We’re thrilled to welcome 𝗟𝗮𝘁𝗵𝗮 𝗞𝗿𝗶𝘀𝗵𝗻𝗮𝗻, our new Logistics, Supply Chain, and Customar Care Specialist in France.

Excited to have you on board, Latha! 💜

hashtag hashtag hashtag hashtag hashtag

📢𝗔𝘀𝗽𝗶𝘃𝗶𝘅 𝗮𝘁 𝗙𝗜𝗚𝗢 𝟮𝟬𝟮𝟱We’re excited to share that a new poster by the renowned Pr Luis Bahamondes on “Evaluation of a Non...
30/09/2025

📢𝗔𝘀𝗽𝗶𝘃𝗶𝘅 𝗮𝘁 𝗙𝗜𝗚𝗢 𝟮𝟬𝟮𝟱

We’re excited to share that a new poster by the renowned Pr Luis Bahamondes on “Evaluation of a Non-Traumatic Device for Cervical Stabilization in Intrauterine Device Insertion” has been approved for presentation at the FIGO World Congress of Gynecology and Obstetrics 2025 in Cape Town in October.

🗓️ 𝗗𝗮𝘁𝗲 & 𝗧𝗶𝗺𝗲: October 5, 12:40 – 12:50
📍 𝗣𝗼𝘀𝘁𝗲𝗿 𝗧𝗼𝘂𝗿 𝟬𝟯 – 𝗦𝘁𝗿𝗲𝗮𝗺: Sexual and Reproductive Health and Rights
👨‍⚕️𝗣𝗿𝗲𝘀𝗲𝗻𝘁𝗲𝗿: Dr. Luis Bahamondes (Brazil)

✨ This study highlights the real-world evaluation of 𝗖𝗮𝗿𝗲𝘃𝗶𝘅®, our atraumatic, clinically tested, FDA-cleared, and CE-marked device designed to make IUD insertions gentler and less painful.

We are proud to contribute to global discussions on advancing women’s health with innovative, patient-centered solutions.

🔗 Learn more about FIGO 2025: https://figo2025.org/

29/09/2025

👀 𝗦𝗲𝗲 𝗖𝗮𝗿𝗲𝘃𝗶𝘅® 𝗶𝗻 𝗮𝗰𝘁𝗶𝗼𝗻.

Gentle. Modern. Effective. 💜

👉 Book your demo now: https://www.myaspivix.us/appointment/2?skip_resource_selection=1

𝗔𝘃𝗮𝗶𝗹𝗮𝗯𝗹𝗲 𝗻𝗼𝘄 𝗶𝗻 𝘁𝗵𝗲 𝗨𝗦 (𝗦𝗼𝘂𝘁𝗵𝗲𝗿𝗻 𝗖𝗮𝗹𝗶𝗳𝗼𝗿𝗻𝗶𝗮 & 𝗡𝗲𝘄 𝗬𝗼𝗿𝗸).


💜 𝗧𝗼𝗱𝗮𝘆 𝗼𝗻 𝗪𝗼𝗿𝗹𝗱 𝗖𝗼𝗻𝘁𝗿𝗮𝗰𝗲𝗽𝘁𝗶𝗼𝗻 𝗗𝗮𝘆, we celebrate the right of every woman to make informed choices about her reproductiv...
26/09/2025

💜 𝗧𝗼𝗱𝗮𝘆 𝗼𝗻 𝗪𝗼𝗿𝗹𝗱 𝗖𝗼𝗻𝘁𝗿𝗮𝗰𝗲𝗽𝘁𝗶𝗼𝗻 𝗗𝗮𝘆, we celebrate the right of every woman to make informed choices about her reproductive health — with dignity, safety, and comfort.

Too often, women avoid IUDs because of pain during insertion with traditional tools like the tenaculum. That’s why we created 𝗖𝗮𝗿𝗲𝘃𝗶𝘅® — a clinically tested, FDA-cleared, and CE-marked alternative designed to make procedures gentler and less painful.

✨ 𝗖𝗼𝗻𝘁𝗿𝗮𝗰𝗲𝗽𝘁𝗶𝗼𝗻 𝘀𝗵𝗼𝘂𝗹𝗱 𝗯𝗲 𝗲𝗳𝗳𝗲𝗰𝘁𝗶𝘃𝗲 𝗮𝗻𝗱 𝗿𝗲𝘀𝗽𝗲𝗰𝘁𝗳𝘂𝗹.
Join us in raising awareness: ask your provider about 𝗖𝗮𝗿𝗲𝘃𝗶𝘅®, and share this message so more women know there’s a better way.

👉 Visit us at www.aspivix.com to learn more about 𝗖𝗮𝗿𝗲𝘃𝗶𝘅® and how it’s transforming women’s health.

🟣 𝗦𝗲𝘅𝘂𝗮𝗹 𝗛𝗲𝗮𝗹𝘁𝗵 𝗶𝘀 𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲.This 𝗦𝗲𝘅𝘂𝗮𝗹 𝗛𝗲𝗮𝗹𝘁𝗵 𝗔𝘄𝗮𝗿𝗲𝗻𝗲𝘀𝘀 𝗠𝗼𝗻𝘁𝗵, we’re putting women’s experiences at the center. At As...
25/09/2025

🟣 𝗦𝗲𝘅𝘂𝗮𝗹 𝗛𝗲𝗮𝗹𝘁𝗵 𝗶𝘀 𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲.

This 𝗦𝗲𝘅𝘂𝗮𝗹 𝗛𝗲𝗮𝗹𝘁𝗵 𝗔𝘄𝗮𝗿𝗲𝗻𝗲𝘀𝘀 𝗠𝗼𝗻𝘁𝗵, we’re putting women’s experiences at the center. At Aspivix, we’re rethinking how sexual and reproductive healthcare is delivered, starting with reducing pain, trauma, and fear during gynecological procedures. Because no woman should avoid essential care out of fear of pain or trauma.

𝗪𝗶𝘁𝗵 𝗖𝗮𝗿𝗲𝘃𝗶𝘅®, 𝗼𝘂𝗿 𝗴𝗼𝗮𝗹 𝗶𝘀 𝘀𝗶𝗺𝗽𝗹𝗲:
To make essential care gentler, safer, and more dignified for every woman. Because access is just the beginning — experience matters, too.

Let’s break the silence, remove the stigma, and continue building a future where sexual health care is as empowering as it is essential.

Learn more: www.aspivix.com

💜 𝗪𝗼𝗺𝗲𝗻 𝗵𝗮𝘃𝗲 𝘄𝗮𝗶𝘁𝗲𝗱 𝗹𝗼𝗻𝗴 𝗲𝗻𝗼𝘂𝗴𝗵.For too long, women’s health has been overlooked.📉 Less than 9% of research funding focu...
25/09/2025

💜 𝗪𝗼𝗺𝗲𝗻 𝗵𝗮𝘃𝗲 𝘄𝗮𝗶𝘁𝗲𝗱 𝗹𝗼𝗻𝗴 𝗲𝗻𝗼𝘂𝗴𝗵.

For too long, women’s health has been overlooked.
📉 Less than 9% of research funding focuses on women.
The cost? Missed opportunities, pain, and lives.

But change is possible.
✨ Breakthroughs like 𝗖𝗮𝗿𝗲𝘃𝗶𝘅® — our clinically tested, FDA-cleared, and CE-marked device — prove that when we design with women in mind, care becomes safer, gentler, and more respectful.

This year, initiatives like Pivotal Ventures, founded by Melissa French Gates + Wellcome Leap are investing $250M into bold ideas for women’s health.

👉 This is a call to action: Women’s health can’t wait another decade.

🔗 Learn more at www.aspivix.com

24/09/2025

💜 Today is National Women’s Health & Fitness Day. we celebrate the strength, resilience, and wellbeing of women everywhere.

✨ Women’s health means supporting strength, prevention, and comfort — in and out of the clinic.

At Aspivix, we believe that health is about access to safe, respectful, and empowering care experiences.

That’s why we developed Carevix® — a clinically tested, FDA-cleared alternative to the traumatic tenaculum. Designed with patients in mind, Carevix® helps make procedures like IUD insertions less painful, so more women can confidently choose the contraceptive method that’s right for them.

👉 Learn more about how Carevix® is redefining women’s healthcare: www.aspivix.com

24/09/2025

👋 𝗪𝗲𝗹𝗰𝗼𝗺𝗲 𝘁𝗼 𝘁𝗵𝗲 𝗧𝗲𝗮𝗺!

We’re thrilled to welcome 𝗠𝗶𝗻𝗴𝗺𝗶𝗻𝗴 𝗗𝗮𝗶, our new Business System Leader in France. Excited to have you on board, Mingming! 💜

Adresse

Route De La Corniche 8
Renens
1066

Öffnungszeiten

Montag 09:00 - 18:00
Dienstag 09:00 - 17:00
Mittwoch 09:00 - 17:00
Donnerstag 09:00 - 17:00
Freitag 09:00 - 17:00

Webseite

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von Aspivix erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.

Die Praxis Kontaktieren

Nachricht an Aspivix senden:

Verknüpfungen

Teilen

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Kategorie

ASPIVIX

ASPIVIX is a Swiss-based medical device company dedicated to R&D, Manufacturing and Sales of technologies for women’s health.

Our vision is to empower women around the world by driving healthcare innovation in areas that are needed the most, thus making a positive impact in women’s everyday life.

Our flagship product, is a next generation, patent protected vacuum-based cervical device that delivers the same manoeuvrability as the traumatic tenaculum - used 80 million times/year - without the reported patient trauma related to pain, bleeding, tissue tear. We believe that women deserve gentler and more modern methods for procedures in gynecology.

Results from “First in Women” Trial in Switzerland are expected in 2H2020.